Ministerial Decree No. 97705 including buprotezin as active substance to Annex I of Presidential Decree No. 115/1997, in compliance with Commission Directive 2011/6/EU

19591 E<l>HMEPII THI KYBEPNHIEnI THI EAAHNIKHI ~HMOKPATIAI nEPIEXOMENA AnOCl>AIEII TEVXOI ~EVTEPO Karnxwp1on Tnc: e>paonKnc: ouo(ac: buprofezin orn napapTI7µa I TOU npoEe>plKOU ()IQTOyµmoc; op18. 115/1997 .;EyKplITTJ, e>L08EITTJ OTT)V oyopa KOi e"A.Ey­ XOC: <pUTOTipOOTOTEUTIKWV npo·(oVTWV OE ouµµop­ cpwon npoc; TTJV oe>ny(a 91/414 Tau Iu11~ou>..1ou, 6nwc; EXEL ouµn>..npw8E1» (A' 104), oE ouµµopcpw­ on npoc; TrJV Oe>ny(o 2011/6/EE TrJC: EmTponfic; TrJC: 20nc; lavouap(ou 2011.................................................................. 3 Ap. <l>uAAou 1429 16 louv(ou 2011 19596 ECl>HMEPII THI KYBEPNHIEnI (TEYXOI LlEYTEPO) Apt0µ. 97705 (3) KOTOXWPLOTJ TTJC: opaOTLKTJC: oucrfac; buprofezin crTo na­ pcipTT]µa I Tou npoeoptKou otaTciyµaTOc; apt9. 115/1997 ~yKplOT], OL09EOT] OTT]V ayopa KOi eAEYXOC: <pUTOTipO­ O"TOTEUTLKWV npo"iOVTWV O"E cruµµop<pWO"T] npoc; TT]V OOT]y(a 91/414 TOU !uµl30UAIOU, 6nwc; exeL ouµnAT]PW 0e(. (A' 104), cre ouµµop<pwori npoc; TTJV Ooriy(a 2011/6/ EE TllC: Ennponfic; TllC: 2011c; lavouap[ou 2011. 01 vnovPro1 OIKONOMIAI, ANTArnNIITIKOTHTAI KAI NA YTIAIAI - ArPOTIKHI ANAnTV:HI KAI TP04>1MnN 'ExoVTac; un611J11: 1. To 6p9po 1 nap. 1, 2 KOi 3 KOi TOU 6p0pou 3 TOU N. 1338/1983 «E<papµoyfi Tou Ko1voT1Kou b.1Ka(ou• (A' 34) 6nwc; TPOTIOTIOLT)0T")KOV on6 TO 6p0po 6 TOU N. 1440/1984 (A' 70) KOL TO ap0po 65 TOU N. 1892/1990 (A' 101) OVTI­ O"TOLXWC:. 2. To 6p0po 14, nepLTIT. KOT' TOU N. 721/1977 (A' 298), 6nwc; npoon~0T")K& µe TO 6p0po 8 nap. 3 TOU N. 2732/1999 (A' 154 ). 3. Triv yvwµoOOTT]OT] YLO TO 1o eeµa, TT]C: 617c; cruveop[­ OOTJC: TOU A.!Y.rE.ct>. TTJC: 1/11/2010. 4. To 6p0po 90 Tou «Kwo1Ka Noµo8ecr(ac; yI0 TTJ Ku­ [3ipvriOTJ KOL Ta Kuf3epVT")TLK6 bpyava» 6nooc; auTfi KW­ OLKono1fi817KE µe TO n.n. 63/2005 (A' 98) KOi TO yeyovoc; OTI an6 TLC: OIOTC1l;e1c; TllC: napoucrac; OTIO(!)OO"llC: O&V npoKaA&frm oancivri oe [36poc; Tou KpaTtKou npouno­ }l.oy1crµou. 5. To n.n. 115/1997 ;-EyKplOT], OLCl8Wll O"TT)V ayopa KOL eA&YXOC: (J)UTOTipOO"TOTEUTLKWV npo"ioVTWV O& ouµµop<pW 01'") npoc; Tf"IV oor,v(a 91/414 Tou !uµf3oull.fou (A' 104/97), 6nwc; exe1 cruµn}l.11pw0d». 6. Triv OOT]yfa 2011/6/EE TT]C: EmTponfic; TT]C: 20T]c; lavou­ ap(ou 2011 (En1011µri E<priµep[oa ap18. L 18 TTJC: 21/1/2011 cr. 0038 - 0040) yI0 TllV KOTOXWPLOTJ TllC: opaOTLKTJC: oucrfac; buprofezin OTO nap6pT17µ0 I TTJC: 0017yfac; 91/414/EOK Tou !uµf3oull.fou crxeT1K6 µe TT] 0108&0TJ <puTonpoOTOT&UTL­ Kwv npo"i6VTCOV OTT")V ayop6. 7. TT] ap18. 271752/21.10.2010 (B' 1673) Ano<pOOT] TOU npw 8unoupyou KOi TOU Ynoupyou AypOTIKTJC: Av6mu~17c; KOi Tpo<p(µwv YLO «ava0&0T] apµoOLOTT]TWV OTOUC: Y<punoup­ youc; AypOTIKTJC: Av6mu~17c; KOi Tpo<pfµwv EMvri - Map(a AnoOTOAOKll KOL lwavvri KouTcrouKo•, ano<pacr(~ouµe: ~p8po 1 !Kon6c; (6p8po 1 TllC: Oorw(ac; 2011/6/EE) Me TT]V napoucra OTIO(J)OOT] TO napapT11µ0 I TOU n.n. 115/1997 ouµnltripwv&TOL woT& va KOTOXWPLOT&f oe auT6 ri opacrTLKTJ ouofa buprofezin ouµ<pwva µe To 6p9po 2 TTJC: napoucrac;, O"& cruµµop<pWOTJ npoc; TT]V Oo11y(a 2011/6/EE Tf"IC: EmTponfic; Tf"IC: 20ric; lavouap(ou 2011 (En(oriµri Ecpri­ µepfoa ap18. L 18 TTJC: 21/1/2011 o. 0038 - 0040). Ap0po 2 (IIapapTT1µa rric; ooriyiac; 2011/6/EE) :Ero tEA.O~ rou IlivaKa rou IlapapriJµmoc; I rou n.o. 115/1997 1rpocrri0srm T] aK6A.ou0ri syypmpiJ: Ap. «325 Kmv.; ovoµaaia1 o.ptOµoi t(lUto1toincnc Buprofezin Apt0. CAS: 953030-84-7 Apt0. CIPAC: 681 Ovoµacria IUPAC I Ka0ap6t1]tCI (I) (Z)-2--rp1-r.-J3ou-ru).1µ1vo- I ~ 985 g/kg 3- tcr07tp07tUA0-5 <patVUAO- l,3,5 0&ta0tll~IV-4-6VTJ 'Evap~TJ lcr)(1>0~ I~ <I>ej3pouapiou 2011 AiJ~TJ TT]<; KCltll)(OOptcrric; 31 11 Iavouapiou 2021 EtOtKE<; 01Cltll~&t<; MEPO~A E1m:ptm:m1 Vil xpricr1µ01mu:i1:m µ6vo ro<; 1:vwµ01cr6vo Kill llKllp&on6vo. MEPO~B fill TI]V E(!)llpµoy{] .!!lV EVllltOlV llPXWV 'tOU lt11pllpTI]µO.T0<; VI rrpt1ti:1 Vil lllµj3crvovtlll urr6'1'rt m crnµrri:pcrcrµllta tT(<; eK0EITT(<; ErrllvEl;EtaITT(<; ytll IT]V ouofa buprofezin, Kill 1oiro<; ta rrpoollpTI]µllta I Kill IT llU.TJ<;, OllOl<; optO'tlK07tOLTJ0T(KllV ll7t0 TI] µ6vtµT( EmtporriJ ')'Ill tT(V tpoqnKiJ llAUOWll Kill 'tT(V U')'Elll tOlV srorov oni:;23 Noi:µJ3piou 2010. Kll,CI IT] auvol1ri( llUTIJ lll;t0A6Y1JITT(, rt llpµ6011l llPXll npfai:1 Vil llnooioa totlli,EpT( rrpoooxft ota i:~iJ<;: ll) O'tT(V llO<j>CIAElll tOJV XEtptcrtrov Kill tOlV 1:pylli;oµtvrov Kill Vil i:l;llo<pllA~ouv 6n 01 6pm XPTJITT(<; i:mj3CIAADUV wv Kll'tCIAAT(AO El;orrl10µ6 ll'tOµtKiJ<; npootaoi111;, 6rrou xpi:1CI/;i:tlll· 13) rt EK0EoT( µfoco i5tll,po<p~<; .rov KO.taVllAro,rov owu<; µi:taj3oAi,s<; TI]<; ouoiu<; buprofezin (llVIAtVTJ) ota i:nel;i:pylloµEVll tp6<ptµll· y) O'tT(V E(jlllpµoy{] .r<; SVOEIKVUOµEVTJ<; ni:pt6oou llvaµoviJ<; yta KllMLEpyi:11:<; llµEt'l'tonopcr<; oi: 01:pµori(mll· 0) O'tOV KIVOUVO ytoc 'tOU<; UOpoj3LOU<; OpyllVtoµou<; Kill Vil i:l;llo<pllA~ouv 6n ot ouv~KE<; XP11ITTI<; i:mj3CIAAOuv Enllpri( µhpll µi:,ptlloµou wu Ktvi5uvou, mp6oov KpivE,lll Ka,CIMT(AO. T( llpµOOtll llPXll sT(TU 'tT(V unol301cii &ml31:j31llOmKrov lIAT(pO<pOptrov 6oov ll<popa wu<; nllpayov-rei:; i:n&l;Epylloill<; Kat µeta,porriJi:; yta 'tT(V EK,iµ11ori .ou KlVOUVOU ytll 'tOU<; KlltaVllAOl,E<;. T( llpµ6ota llpxft µEATI El;llO<pllAisEt 6n O CllTWV urroj3CIMEl Tt<; EV Myro 1:ml31:j31luonKE<; rrAT(po<popiEi:; a,T(V EnnponiJ EOl<; n<; 31 Tavoullpiou 2013.» ITT Ilepattspoo A.Emoµspeiec; crxertKa µe tT(V raur6trtra Km n~ npoomypacpsc; trtc; opacrttKTJ<; oucriac; napsxovrm otrtv sK0eofJ avacrK61tTJcrTJc;. m & :c s: m :!! M I :c M " < m m "1J z :c M m ::, M =i m ~ 0 M t> m =i m "1J 0 ., ~ 19598 ECl>HMEPII THI KYBEPNHIEnI (TEYXOI LlEYTEPO) J\p6po 3 (6p6po 2 TTlC: O5riyfac: 2011/6/EE) 01 510T6f;e1c: TTlC: napoucrac: an6cpocrric: 1crxuouv an6 TfJV 1fl AuyOUOTOU 2011. H an6cpacrri OUTTJ va 5riµomeueef OTTlV Ecpriµepf5a TTlC: Ku~epvficrewc;. A917va, 8 louv[ou 2011 01 vnOYPrDI OIKONOMIAL, ANTArQNIITIKOTHTAr Y<l>Yn. A,POTIKHr ANAnTY::Hr KAI NAYTIJ\IA'.> KAI TPO<DIMON MIXAHJ\ XPVIOXO"ib.HI lnANNHI KOVTIOVKOI 11111111111111111111111111111111111111111111111111111111111111111111111111111111111111111111111 * 0 2 0 1 4 2 9 1 6 0 6 1 1 0 0 1 2 *